[Increased digitalis-like activity in combined administration of calcium antagonists and digitalis preparations].
It is well recognized that the co-administration of some drugs to persons receiving digoxin results in an increase of serum digoxin levels: it occasionally precipitates digoxin toxicity. There are some possible mechanisms by which different drugs may increase serum glycoside levels: 1) by displacing digoxin from tissue binding sites, 2) by decreasing digoxin renal excretion, 3) by enhancing digoxin absorption, 4) by increasing the inhibition of the ATP-dependent pump. Combined administration of calcium antagonists and B-methyldigoxin is common in patients with heart diseases. Other Authors have found that the co-administration of these drugs with digoxin increases glycoside serum levels, without signs of intoxication. We have examined the effects of this combination on digitalis activity, by Rubidium 86 uptake in erythrocytes. Thirty patients aged 52 to 66 with congestive heart failure were studied. All of these had normal serum creatinine, blood urea and serum protein levels. These subjects received 0,20 mg of B-methyldigoxin daily for nine days; afterwards, ten of them were given in addition 320 mg of verapamil for seven days; the other ten received in addition 60 mg of nifedipine, for seven days; the remaining ten patients received in addition 320 mg of verapamil and 60 mg of nifedipine together, for seven days. Digoxin activity was measured on the eighth, ninth and sixteenth day of treatment by Rubidium 86 uptake in erythrocytes. The technique was that of Bertler. Means were compared with the t test, with the assumption of the equal variances in the two groups.(ABSTRACT TRUNCATED AT 250 WORDS)
D000368:Aged; D004077:Digoxin / Q000031:analogs & derivatives* / Q000097:blood; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006333:Heart Failure / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D008520:Medigoxin / Q000627:therapeutic use*; D008875:Middle Aged; D009543:Nifedipine / Q000097:blood / Q000627:therapeutic use*; D014700:Verapamil / Q000097:blood / Q000627:therapeutic use*
D004077:Digoxin; D014700:Verapamil; D008520:Medigoxin; D009543:Nifedipine
Aumentata attività digitalica nella somministrazione contemporanea di calcioantagonisti e digitalici.